We aim to——
design novel antibodies to target antigen epitopes precisely

By integrating

Deep
learning
Structural
biology
High-throughput
techniques
Our platform enables more efficient discovery, and with a higher successful rate, compared to traditional methods.

OurInvestor

Xiang He Capital
5Y CAPITAL
HillHouse
GAORONG CAPITAL